BIRC2 and listeriosis: Considering the increased in vivo degradation of c-IAP1 in the absence of OTUB1 (Fig. 3A, B), we studied whether OTUB1 protects hepatic c-IAP1 against proteasomal degradation in listeriosis and upon D-Gal/TNF treatment.